Genmab Acquires A Missing Piece For Its Pipeline (NASDAQ:GMAB)

Published on 16 Apr 2024 on Seeking Alpha

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the...

Read the rest of the article

Start tracking your investments with Statfolio

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the...

Seeking Alpha 16 Apr 2024

Genmab A/S (NASDAQ:GMAB) disclosed on Monday that the first quarter of 2024 saw robust sales of...

Investing.com 16 Apr 2024

At least nine large law firms got a share of the work from Silver Lake's buy of Endeavor Group. T...

Law.com 8 Apr 2024

The company makes implantable lenses to help improve vision. During the first quarter, Staar says...

Investor's Business Daily 4 Apr 2024

**Walt Disney (DIS)**: The entertainment giant's shareholder meeting was due to start at 1 p.m. E...

The Wall Street Journal 3 Apr 2024

The company uses its HexaBody platform to make "supercharged" antibodies capable of quelling spec...

Investor's Business Daily 3 Apr 2024

But we have not shied away from making tough decisions around prioritizing or deprioritizing...

Investor's Business Daily 3 Apr 2024

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.67%

Investing.com 1 Apr 2024

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.67%

Investing.com 28 Mar 2024

Genmab AS (NASDAQ:GMAB) is one of the largest Danish pharmaceutical companies focused on developi...

GuruFocus.com via Yahoo Finance 15 Feb 2024